SCHEMBL9540089

SCHEMBL9540089

C=CCC1(c2ccccc2)NC(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 5/20 0.46
PDE7A Q13946 2/20 0.44
AKR1B1 P15121 5/20 0.41
ADAMTS5 Q9UNA0 5/20 0.39
MMP2 P08253 3/20 0.39
MMP13 P45452 3/20 0.39
ADAMTS4 O75173 1/20 0.39
MMP3 P08254 1/20 0.39
MMP14 P50281 1/20 0.39
AKR1A1 P14550 2/20 0.38
IDO1 P14902 1/20 0.38
PGR P06401 1/20 0.38
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9539139 0.81 PDE7A (0.43) ADAM17PDE7AAKR1B1MMP2MMP3
SCHEMBL9542686 0.79 ADAM17 (0.48) ADAM17PDE7AAKR1B1ADAMTS5MMP2
SCHEMBL9542760 0.79 ADAM17 (0.45) ADAM17PDE7AAKR1B1ADAMTS5MMP2
SCHEMBL9540154 0.79 PDE7A (0.50) PDE7AAKR1B1AKR1A1IDO1PGR
SCHEMBL9541372 0.73 AKR1B1 (0.45) PDE7AAKR1B1AKR1A1IDO1PGR
SCHEMBL9539773 0.73 PDE7A (0.48) ADAM17PDE7AAKR1B1ADAMTS5MMP2
SCHEMBL21940203 0.73 PDE7A (0.50) ADAM17PDE7AAKR1B1AKR1A1IDO1
SCHEMBL9539809 0.71 PDE7A (0.48) ADAM17PDE7AAKR1B1AKR1A1PGR
SCHEMBL9539947 0.71 PDE7A (0.45) PDE7AAKR1B1AKR1A1IDO1PGR
SCHEMBL2471238 0.70 MAPT (0.36) AKR1B1IDO1PGRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed